Different Way

The point of personalized medicine, as the mantra goes, is to bring the right treatment to the right patient at the right time. But getting such tailored therapies approved may mean that how clinical trials assessing their efficacy and safety are conducted needs to be re-thought, writes Susan Young at Technology Review.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

The Pair of Them

An Understanding

This Week in Nature

Barriers and Promise

This Week in Science

The World Health Organization calls for the public release of clinical trial results within a year of the completion of data collection.

In Science this week: measles virus nucleocapsid structure, and more.

African and US health officials work to establish an Africa-wide Centres for Disease Control and Prevention.

Nature has retracted a 2002 epigenetics paper for image manipulation.